|
[1]de STEFANO V, MARTINELLI I.Splanchnic vein thrombosis:clinical presentation, risk factors and treatment[J].Intern Emerg Med, 2010, 5 (4) :487-494.
|
|
[2]de LEVE LD, VALLA DC, GARCIA-TSAO G.Vascular disorders of the liver[J].Hepatology, 2009, 49 (5) :1729-1764.
|
|
[3]GAO Y, JIA JD.2009 AASLD Vascular disorders of the liver practice guidelines[J].J Clin Hepatol, 2010, 26 (1) :9-13. (in Chinese) 高岩, 贾继东.2009年AASLD肝脏血管疾病诊疗指南要点[J].临床肝胆病杂志, 2010, 26 (1) :9-13.
|
|
[4]WANG ZG, LI CM, LI Z, et al.Evolution and prospects of Budd-Chiari syndrome[J].J Clin Hepatol, 2011, 27 (2) :113-115. (in Chinese) 汪忠镐, 李春民, 李震, 等.布-加综合征的进展与展望[J].临床肝胆病杂志, 2011, 27 (2) :113-115.
|
|
[5]ZHANG W, YU YZ.Application of multi-slice spiral CT angiography in the diagnosis and treatrnent of portal hypertension[J].Chin J Pract Intern Med, 2012, 32 (1) :72-74. (in Chinese) 张伟, 于永征.多排螺旋CT血管成像在门静脉高压诊治中的应用[J].中国实用内科杂志, 2012, 32 (1) :72-74.
|
|
[6]QI X, HU F, YANG Z, et al.JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis[J].Aliment Pharmacol Ther, 2011, 33 (4) :495-496.
|
|
[7]QI X, ZHANG C, HAN G, et al.Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis:a prospective study[J].J Gastroenterol Hepatol, 2012, 27 (6) :1036-1043.
|
|
[8]QI X, WU F, REN W, et al.Thrombotic risk factors in Chinese Budd-Chiari syndrome patients.An observational study with a systematic review of the literature[J].Thromb Haemost, 2013, 109 (5) :878-884.
|
|
[9]QI X, HE C, HAN G, et al.Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis[J].J Gastroenterol Hepatol, 2013, 28 (1) :148-152.
|
|
[10]QI X, DE STEFANO V, WANG J, et al.Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome:A systematic review and meta-analysis of observational studies[J].J Gastroenterol Hepatol, 2013, 28 (3) :432-442.
|
|
[11]BERTINA RM, KOELEMAN BP, KOSTER T, et al.Mutation in blood coagulation factor V associated with resistance to activated protein C[J].Nature, 1994, 369 (6475) :64-67.
|
|
[12]EMMERICH J, ROSENDAAL FR, CATTANEO M, et al.Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism-pooled analysis of 8 case-control studies including2310 cases and 3204 controls.Study Group for Pooled-Analysis in Venous Thromboembolism[J].Thromb Haemost, 2001, 86 (3) :809-816.
|
|
[13]BOEKHOLDT SM, BIJSTERVELD NR, MOONS AH, et al.Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction:a systematic review[J].Circulation, 2001, 104 (25) :3063-3068.
|
|
[14]DONAHUE BS, GAILANI D, HIGGINS MS, et al.Factor V Leiden protects against blood loss and transfusion after cardiac surgery[J].Circulation, 2003, 107 (7) :1003-1008.
|
|
[15]de STEFANO V, CHIUSOLO P, PACIARONI K, et al.Epidemiology of factor V Leiden:clinical implications[J].Semin Thromb Hemost, 1998, 24 (4) :367-379.
|
|
[16]DENNINGER MH, BELDJORD K, DURAND F, et al.BuddChiari syndrome and factor V Leiden mutation[J].Lancet, 1995, 345 (8948) :525-526.
|
|
[17] MAHMOUD AE, WILDE JT, ELIAS E.Budd-Chiari syndrome and factor V Leiden mutation[J].Lancet, 1995, 345 (8948) :526-526.
|
|
[18]LEVOIR D, EMMERICH J, ALHENC-GELAS M, et al.Portal vein thrombosis and factor V Arg 506 to Gln mutation[J].Thromb Haemost, 1995, 73 (3) :550-551.
|
|
[19]DENNINGER MH, HELLEY D, VALLA D, et al.Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis[J].Thromb Haemost, 1997, 78 (4) :1297-1298.
|
|
[20]MAHMOUD AE, ELIAS E, BEAUCHAMP N, et al.Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis[J].Gut, 1997, 40 (6) :798-800.
|
|
[21]JANSSEN HL, MEINARDI JR, VLEGGAAR FP, et al.Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis:results of a case-control study[J].Blood, 2000, 96 (7) :2364-2368.
|
|
[22]DENTALI F, GALLI M, GIANNI M, et al.Inherited thrombophilic abnormalities and risk of portal vein thrombosis.a meta-analysis[J].Thromb Haemost, 2008, 99 (4) :675-682.
|
|
[23]FENG B, XU K, JIANG H, et al.Relationship between factor V Leiden mutation and Chinese Budd-Chiari syndrome and its clinical significance[J].Chin Med J, 2000, 80 (5) :354-357. (in Chinese) 冯博, 徐克, 姜宏, 等.Fv Leiden突变与我国汉族人布-加综合征的相关性及其临床意义[J].中华医学杂志, 2000, 80 (5) :354-357.
|
|
[24]ZHENG H, LIAN JH, QI H, et al.FV Leiden and FIIG20210A mutations in patients with Budd-Chiari syndrome[J].J Zhengzhou Univ:Med Sci, 2005, 40 (3) :456-458. (in Chinese) 郑红, 连建华, 齐华, 等.布-加综合征患者FVLeiden, FIIG20210A突变检测[J].郑州大学学报:医学版, 2005, 40 (3) :456-458.
|
|
[25]LIN GL, XU PQ, QI H, et al.A study on the correlations between pathogenesis of Budd-Chiari syndrome and Factor V Leiden and Factor II G20210A mutations[J].Chin J Gen Surg, 2006, 21 (4) :275-277. (in Chinese) 林国领, 许培钦, 齐华, 等.布加综合征与凝血因子V Leiden及凝血酶原基因G20210A突变的关系研究[J].中华普通外科杂志, 2006, 21 (4) :275-277.
|
|
[26]YU CW, GAO Y, GENG XP, et al.The research on the mutation of coagulation factor V of diseased tissues in Budd-Chiari Syndrome[J].J Clin Surg, 2007, 15 (11) :743-745. (in Chinese) 余朝文, 高涌, 耿小平, 等.布加综合征病变组织因子V突变的研究[J].临床外科杂志, 2007, 15 (11) :743-745.
|
|
[27]CHENG D, XU H, LU ZJ, et al.Clinical features and etiology of Budd-Chiari syndrome in Chinese patients:a single-center study[J].J Gastroenterol Hepatol, 2013, 28 (6) :1061-1067.
|
|
[28]QI X, WANG J, REN W, et al.Familial Budd-Chiari syndrome in China:A systematic review of the literature[J].ISRN Hepatology, 2013, 2013 (2013) :1-7.
|
DownLoad: